Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 06.12.2015

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
06.12.15AbbVie Announces New England Journal of Medicine Online Publication of Venetoclax Phase 1 Data in Relapsed/Refractory Chronic Lymphocytic Leukemia86-- Primary outcome measures included dose level findings and safety assessment -- Overall response rate in 116 patients, a secondary outcome measure, was 79 percent (n=92/116) with 20 percent (n=32/116)...
► Artikel lesen
06.12.15AbbVie Reports Phase 2 Results of Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients with 17p Deletion131- Venetoclax monotherapy response rates, including Complete Remissions, reported in Phase 2 study of relapsed/refractory chronic lymphocytic leukemia patients with 17p deletion - Study of investigational...
► Artikel lesen
06.12.15BESIX Group: Public-Private Partnerships the Solution to Affordable Infrastructure Development in the Middle East88SHARJAH, UAE, December 6, 2015 /PRNewswire/ -- BESIX celebrates 'Sharjah: 40 Years of Achievements' On 6 December, BESIX Group, Belgium's largest construction company, is celebrating 40 years...
► Artikel lesen
06.12.15Diebold And Alhamrani Universal Company Extend Agreement To Deliver Innovative Banking Solutions To The Saudi Arabian Market103RIYADH, Saudi Arabia, Dec. 6, 2015 /PRNewswire/ -- Diebold and Alhamrani Universal Company have announced the renewal of their distribution agreement in the Kingdom of Saudi Arabia. The four-year...
► Artikel lesen